Van Poznak C - Search Results

1

Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.

Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Hurria A, Holland J. Hurria A, et al. Among authors: van poznak c, van gorp wg. J Am Geriatr Soc. 2006 Jun;54(6):925-31. doi: 10.1111/j.1532-5415.2006.00732.x. J Am Geriatr Soc. 2006. PMID: 16776787

2

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.

Van Poznak C, Seidman AD, Reidenberg MM, Moasser MM, Sklarin N, Van Zee K, Borgen P, Gollub M, Bacotti D, Yao TJ, Bloch R, Ligueros M, Sonenberg M, Norton L, Hudis C. Van Poznak C, et al. Among authors: van zee k. Breast Cancer Res Treat. 2001 Apr;66(3):239-48. doi: 10.1023/a:1010686204736. Breast Cancer Res Treat. 2001. PMID: 11510695 Clinical Trial.

3

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer.

Van Poznak C, Tan L, Panageas KS, Arroyo CD, Hudis C, Norton L, Seidman AD. Van Poznak C, et al. J Clin Oncol. 2002 May 1;20(9):2319-26. doi: 10.1200/JCO.2002.08.125. J Clin Oncol. 2002. PMID: 11981003

4

HER2 testing and correlation with efficacy of trastuzumab therapy.

Fornier M, Risio M, Van Poznak C, Seidman A. Fornier M, et al. Among authors: van poznak c. Oncology (Williston Park). 2002 Oct;16(10):1340-8, 1351-2; discussion 1352, 1355-8. Oncology (Williston Park). 2002. PMID: 12435204 Review.

5

The use of bisphosphonates in patients with breast cancer.

Van Poznak CH. Van Poznak CH. Cancer Control. 2002 Nov-Dec;9(6):480-9. doi: 10.1177/107327480200900605. Cancer Control. 2002. PMID: 12514566 Free article. Review.

6

Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer.

Modi S, DiGiovanna MP, Lu Z, Moskowitz C, Panageas KS, Van Poznak C, Hudis CA, Norton L, Tan L, Stern DF, Carter D, Seidman AD. Modi S, et al. Among authors: van poznak c. Cancer Invest. 2005;23(6):483-7. doi: 10.1080/07357900500201301. Cancer Invest. 2005. PMID: 16203655

7

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.

Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I. Van Poznak C, et al. J Clin Pathol. 2006 Jan;59(1):56-63. doi: 10.1136/jcp.2005.026534. J Clin Pathol. 2006. PMID: 16394281 Free PMC article.

8

Bone integrity and bone metastases in breast cancer.

Van Poznak C, Nadal C. Van Poznak C, et al. Curr Oncol Rep. 2006 Jan;8(1):22-8. doi: 10.1007/s11912-006-0005-9. Curr Oncol Rep. 2006. PMID: 16464399

9

The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.

Van Poznak C. Van Poznak C. Cancer Invest. 2006 Feb;24(1):110-2. doi: 10.1080/07357900500449652. Cancer Invest. 2006. PMID: 16467002

10

Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.

Hurria A, Goldfarb S, Rosen C, Holland J, Zuckerman E, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Robson M, Currie VE, Theodoulou M, Norton L, Hudis C. Hurria A, et al. Among authors: van poznak c, van gorp wg. Breast Cancer Res Treat. 2006 Aug;98(3):343-8. doi: 10.1007/s10549-006-9171-6. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page